We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Phoqus | LSE:PQS | London | Ordinary Share | GB00B0M4CD64 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 8.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number : 3767A
Phoqus Pharmaceuticals PLC
31 July 2008
Phoqus Pharmaceuticals plc update
West Malling, UK, 31 July 2008: Phoqus Pharmaceuticals plc ("Phoqus" or the "Company") (LSE: PQS) announces that its Nominated adviser
and broker Nomura Code Securities Limited has resigned with immediate effect.
Enquiries:
Grant Thornton UK LLP Tel: 02077282560
Daniel Linaker
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFKDKPQBKDKON
1 Year Phoqus Chart |
1 Month Phoqus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
